Effects of the MAML2 genetic variants in glioma susceptibility and prognosis.
CONCLUSION: We provided some novel data suggesting MAML2 polymorphisms might contribute to glioma risk and prognosis. Future studies are warranted to validate these findings and characterize mechanisms underlying these associations.
PMID: 31652449 [PubMed - in process]
Source: Bioscience Reports - Category: Biomedical Science Authors: Zhang M, Zhao Y, Zhao J, Huang T, Guo X, Ma X, Wu Y Tags: Biosci Rep Source Type: research
More News: Astrocytoma | Biomedical Science | Brain Tumor | Cancer | Cancer & Oncology | China Health | Genetics | Glioma | Study